Literature DB >> 19023869

Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.

Ci Ma1, Mayumi Yoshioka, André Boivin, Lin Gan, Yasukazu Takase, Fernand Labrie, Jonny St-Amand.   

Abstract

BACKGROUND: Using serial analysis of gene expression (SAGE), we studied the transcriptomic changes in vivo by dihydrotestosterone (DHT) treatment in mice to better understand androgen effects in the prostate.
METHODS: Approximately 872,000 SAGE tags were isolated from intact and castrated (GDX) mice with and without DHT injection.
RESULTS: GDX significantly altered 431 transcripts, including 110 transcripts restored by DHT, and 146 potentially new transcripts. Totally, 187 transcripts were significantly affected by DHT treatment, of which 124 were induced and 63 were repressed. Interestingly and consistent with the prostate's secretory role, DHT up-regulated the expression of many genes involved in various steps of protein metabolism such as synthesis, folding, and secretion. GDX modulated the expression of genes which induce cell apoptosis and inhibit cell proliferation through polyamine biosynthesis, retinoid X receptor actions as well as several signaling pathways and some related factors. These results clarify DHT effects on prostate transcriptome in the areas of protein metabolism, cell proliferation and apoptosis. In addition, we detected gene expression changes in metabolic pathways, cytoskeleton, immunity and endoplasmic reticulum stress. Furthermore, knockdown of S-adenosylmethionine decarboxylase 1 in LNCaP cells confirmed the importance of androgen-regulated genes (ARGs) in prostate cancer cell growth.
CONCLUSION: Our data support the idea that ARGs are essential for the normal development of the prostate and can also be responsible for the pathogenesis of the prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19023869     DOI: 10.1002/pros.20883

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.

Authors:  Sandra M Lopez; Alexander I Agoulnik; Manqi Zhang; Leif E Peterson; Egla Suarez; Gregory A Gandarillas; Anna Frolov; Rile Li; Kimal Rajapakshe; Christian Coarfa; Michael M Ittmann; Nancy L Weigel; Irina U Agoulnik
Journal:  Clin Cancer Res       Date:  2016-03-11       Impact factor: 12.531

2.  The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction.

Authors:  Jinrong Cheng; Yue Wu; James L Mohler; Clement Ip
Journal:  Cancer Biol Ther       Date:  2010-06-24       Impact factor: 4.742

3.  Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Authors:  Katja Jehle; Laura Cato; Antje Neeb; Claudia Muhle-Goll; Nicole Jung; Emmanuel W Smith; Victor Buzon; Laia R Carbó; Eva Estébanez-Perpiñá; Katja Schmitz; Ljiljana Fruk; Burkhard Luy; Yu Chen; Marc B Cox; Stefan Bräse; Myles Brown; Andrew C B Cato
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

4.  Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells.

Authors:  H L Bennett; J T Fleming; J O'Prey; K M Ryan; H Y Leung
Journal:  Cell Death Dis       Date:  2010-09-09       Impact factor: 8.469

Review 5.  Prostate cancer and the unfolded protein response.

Authors:  Margrethe Storm; Xia Sheng; Yke Jildouw Arnoldussen; Fahri Saatcioglu
Journal:  Oncotarget       Date:  2016-08-16

6.  Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism.

Authors:  Giuseppe Grande; Federica Vincenzoni; Francesca Mancini; Ferran Barrachina; Antonella Giampietro; Massimo Castagnola; Andrea Urbani; Rafael Oliva; Domenico Milardi; Alfredo Pontecorvi
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.